<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Clinical Practice</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Clinical Practice</journal-title><trans-title-group xml:lang="ru"><trans-title>Клиническая практика</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-3095</issn><issn publication-format="electronic">2618-8627</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107847</article-id><article-id pub-id-type="doi">10.17816/clinpract107847</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original Study Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Induced blood oxidation in myocardial revascularization</article-title><trans-title-group xml:lang="ru"><trans-title>Показатели индуцированного окисления крови при проведении реваскуляризации миокарда</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5362-8702</contrib-id><contrib-id contrib-id-type="spin">3521-7810</contrib-id><name-alternatives><name xml:lang="en"><surname>Shereshneva</surname><given-names>Marina V.</given-names></name><name xml:lang="ru"><surname>Шерешнева</surname><given-names>Марина Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>m.shereshneva@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6278-374X</contrib-id><contrib-id contrib-id-type="spin">2936-4312</contrib-id><name-alternatives><name xml:lang="en"><surname>Ilyin</surname><given-names>Mikhail  V.</given-names></name><name xml:lang="ru"><surname>Ильин</surname><given-names>Михаил Витальевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>МD, PhD, Associate Professor</p></bio><bio xml:lang="ru"><p>д.м.н., доцент</p></bio><email>dekanat-2011@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5219-2145</contrib-id><contrib-id contrib-id-type="spin">3806-1033</contrib-id><name-alternatives><name xml:lang="en"><surname>Sandugey</surname><given-names>Anna V.</given-names></name><name xml:lang="ru"><surname>Сандугей</surname><given-names>Анна Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>МD, PhD, Assistent</p></bio><bio xml:lang="ru"><p>к.м.н., ассистент</p></bio><email>sandugey1@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2385-7456</contrib-id><contrib-id contrib-id-type="spin">9315-6570</contrib-id><name-alternatives><name xml:lang="en"><surname>Zotov</surname><given-names>Alexander S.</given-names></name><name xml:lang="ru"><surname>Зотов</surname><given-names>Александр Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>МD, PhD</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>zotov.alex.az@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Yaroslavl State Medical University</institution></aff><aff><institution xml:lang="ru">Ярославский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency</institution></aff><aff><institution xml:lang="ru">Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства России</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2022-06-20" publication-format="electronic"><day>20</day><month>06</month><year>2022</year></pub-date><pub-date date-type="pub" iso-8601-date="2022-07-03" publication-format="electronic"><day>03</day><month>07</month><year>2022</year></pub-date><volume>13</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>20</fpage><lpage>28</lpage><history><date date-type="received" iso-8601-date="2022-05-16"><day>16</day><month>05</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-06-07"><day>07</day><month>06</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Shereshneva M.V., Ilyin M.V., Sandugey A.V., Zotov A.S.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Шерешнева М.В., Ильин М.В., Сандугей А.В., Зотов А.С.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Shereshneva M.V., Ilyin M.V., Sandugey A.V., Zotov A.S.</copyright-holder><copyright-holder xml:lang="ru">Шерешнева М.В., Ильин М.В., Сандугей А.В., Зотов А.С.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://clinpractice.ru/clinpractice/article/view/107847">https://clinpractice.ru/clinpractice/article/view/107847</self-uri><abstract xml:lang="en"><p><bold><italic>Background:</italic></bold><italic> The use of artificial circulation in surgical myocardial revascularization is one of the key pathogenetic factors in the development of the oxidative stress and systemic inflammatory response in the postoperative period. <bold>Aims:</bold> the purpose of the study was to describe the dynamics of the induced blood oxidation parameters during coronary artery bypass surgery in the conditions of artificial circulation and on the working heart. <bold>Methods:</bold> The study included 64 patients who underwent coronary bypass surgery, with 31 (48.4%) on-pump patients and 33 (51.6%) off-pump patients. The oxidative stress simulations were conducted under the in vitro conditions. The blood oxidation-induced values were studied using a biological oxygen monitor. <bold>Results:</bold> In patients with coronary heart disease, regardless of the choice of the revascularization method (on-pump / off-pump), we observed statistically significantly (p &lt;0.05) higher initial and maximum blood oxidation rates, the oxidative activity factor, and a shorter initiation period than those in healthy volunteers. No significant differences were found by the inter-group comparison analysis both 10 days and 6 months post-surgery. <bold>Conclusion:</bold> The indicators of induced blood oxidation do not depend on the method of revascularization during coronary bypass grafting (artificial circulation or a working heart). The changes in the parameters indicating activation of the oxidative and antioxidant blood systems may be transient by their nature and occur in the early postoperative period.</italic></p></abstract><trans-abstract xml:lang="ru"><p><bold><italic>Обоснование.</italic></bold><italic> Применение искусственного кровообращения при проведении хирургической реваскуляризации миокарда является одним из ключевых патогенетических факторов в развитии окислительного стресса и системного воспалительного ответа в послеоперационном периоде. <bold>Цель исследования</bold> — изучение динамики показателей индуцированного окисления крови при шунтировании коронарных артерий в условиях искусственного кровообращения и на работающем сердце. <bold>Методы.</bold> В исследование включены 64 пациента, которым было выполнено коронарное шунтирование, из них 31 (48,4%) прооперирован в условиях искусственного кровообращения (on-pump), 33 (51,6%) — с вмешательством на работающем сердце (off-pump). Моделирование окислительного стресса проводилось в условиях in vitro. Показатели индуцированного окисления крови изучались с помощью биологического кислородного монитора. <bold>Результаты.</bold> У больных ишемической болезнью сердца вне зависимости от выбора методики реваскуляризации (on-pump / off-pump) наблюдались статистически значимо (p &lt;0,05) более высокие, чем у здоровых добровольцев, показатели инициальной и максимальной скорости окисления крови, коэффициент окислительной активности и более короткий период инициации. При проведении межгруппового сравнительного анализа значимых различий не наблюдалось как через 10 сут, так и через 6 мес после операции. <bold>Заключение.</bold> Показатели индуцированного окисления крови не зависят от метода реваскуляризации — коронарного шунтирования в условиях искусственного кровообращения или на работающем сердце. Изменения показателей, свидетельствующие об активации окислительной и антиоксидантной систем крови, могут носить транзиторный характер и возникать в раннем послеоперационном периоде.</italic></p></trans-abstract><kwd-group xml:lang="en"><kwd>atherosclerosis</kwd><kwd>oxidative stress</kwd><kwd>coronary heart disease</kwd><kwd>revascularization</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>атеросклероз</kwd><kwd>окислительный стресс</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>реваскуляризация</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: A report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am College Cardiol. 2017;24(5):1759–1792. doi: 10.1007/s12350-017-0917-9</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Pillai JB, Suri RM. Coronary artery surgery and extracorporeal circulation: the search for a new standard. J Cardiothorac Vasc Anesth. 2008;22(4):594–610. doi: 10.1053/j.jvca.2008.02.004</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Zhu H, Xu X, Ding Y, et al. Effects of prostaglandin E1 on reperfusion injury patients: a meta-analysis of randomized controlled trials. Medicine. 2017;96(15):e6591. doi: 10.1097/MD.0000000000006591</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Vukicevic P, Klisic A, Kotur-Stevuljevic J, et al. Paraoxonase 1 low activity and SYNTAX score may predict postoperative complications after coronary artery surgery. Eur Rev Med Pharmacol Sci. 2021;25(3):1511–1521. doi: 10.26355/eurrev_202102_24858</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Alam SR, Stirrat C, Spath N, et al. Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery. J Cardiothorac Surg. 2017;12(1):115. doi: 10.1186/s13019-017-0681-6</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Shafiei E, Bahtoei M, Raj P, et al. Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass grafting: a randomized, open-labeled, placebo-controlled trial. Medicine. 2018;97(30):e11383. doi: 10.1097/MD.0000000000011383</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Papadakis E, Kanakis M, Kataki A, Spandidos DA. The spectrum of myocardial homeostasis mechanisms in the settings of cardiac surgery procedures (review). Mol Med Reports. 2018; 17(2):2089–2099. doi: 10.3892/mmr.2017.8174</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Stevens JL, Feelisch M, Perioperative DS. Oxidative stress: the unseen enemy. Anesthesia Analgesia. 2019;129(6):1749–1760. doi: 10.1213/ANE.0000000000004455</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Zhao H, Kilgas S, Alam A, et al. The role of extracellular adenosine triphosphate in ischemic organ injury. Critical Care Med. 2016;44(5):1000–1012. doi: 10.1097/CCM.0000000000001603</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Werber J, Wang YJ, Milligan M, et al. Analysis of 2,2’-azobis (2-amidinopropane) dihydrochloride degradation and hydrolysis in aqueous solutions. J Pharm Sci. 2011;100(8):3307–3315. doi: 10.1002/jps.22578</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Magro P, Boshoff S, Calquinha J, et al. CABG: to CBP or not to CBP — a propensity score matched survival. Rev Port Cir Cardiotorac Vasc. 2017;24(3-4):102.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Hueb W, Rezende PC, Gersh BJ, et al. Ten-year follow-up of off-pump and on-pump multivessel coronary artery bypass grafting: MASS III. Angiology. 2019;70(4):337–344. doi: 10.1177/0003319718804402</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Kirmani BH, Guo H, Ahmadyur O, Bittar MN. Long-term survival following on-pump and off-pump coronary artery bypass graft surgery: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2019;56(6):1147–1153. doi: 10.1093/ejcts/ezz250</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Deutsch MA, Zittermann A, Renner A, et al. Risk-adjusted analysis of long-term outcomes after on- versus off-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2021;33(6):857–865. doi: 10.1093/icvts/ivab179</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Van den Eynde J, Bomhals K, Noé D, et al. Revascularization strategies in patients with multivessel coronary artery disease: a Bayesian network meta-analysis. Interact Cardiovasc Thorac Surg. 2022;34(6):947–957. doi: 10.1093/icvts/ivab376</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Numata S, Kumamaru H, Miyata H, et al. Comparison of long-term outcomes between off-pump and on-pump coronary artery bypass grafting using Japanese nationwide cardiovascular surgery database. Gen Thorac Cardiovasc Surg. 2022;70(6):531–540. doi: 10.1007/s11748-021-01731-0</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Machado RJ, Saraiva FA, Mancio J, et al. A systematic review and meta-analysis of randomized controlled studies comparing off-pump versus on-pump coronary artery bypass grafting in the elderly. J Cardiovasc Surg (Torino). 2022;63(1):60–68. doi: 10.23736/S0021-9509.21.12012-9</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Wang Y, Zhu S, Gao P, et al. Off-pump versus on-pump coronary surgery in patients with chronic kidney disease: a meta-analysis. Clin Exp Nephrol. 2018;22(1):99–109. doi: 10.1007/s10157-017-1432-7</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Rocha RV, Yanagawa B, Hussain MA, et al. Off-pump versus on-pump coronary artery bypass grafting in moderate renal failure. J Thorac Cardiovasc Surg. 2020;159(4):1297–1304.e2. doi: 10.1016/j.jtcvs.2019.03.142</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Zubarevich A, Kadyraliev B, Arutyunyan V, et al. On-pump versus off-pump coronary artery bypass surgery for multi-vessel coronary revascularization. Journal of thoracic disease. 2020;12(10):5639–5646. doi: 10.21037/jtd-20-1284</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Guan Z, Guan X, Gu K, et al. Short-term outcomes of on- vs off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: a systematic review and meta-analysis. J Cardiothorac Surg. 2020;15(1):84. doi: 10.1186/s13019-020-01115-0</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Plicner D, Stoliński J, Wąsowicz M, et al. Preoperative values of inflammatory markers predict clinical outcomes in patients after CABG, regardless of the use of cardiopulmonary bypass. Indian Heart J. 2016;68:S10–S15. doi: 10.1016/j.ihj.2016.10.002</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Yamamoto M, Nishimori H, Fukutomi T, et al. Dynamics of oxidative stress evoked by myocardial ischemia reperfusion after off-pump coronary artery bypass grafting elucidated by bilirubin oxidation. Circ J. 2017;81(11):1678–1685. doi: 10.1253/circj.CJ-16-1116</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Останко В.Л., Калачева Т.П., Калюжина Е.В., и др. Биологические маркеры в стратификации риска развития и прогрессирования сердечно-сосудистой патологии: настоящее и будущее // Бюллетень сибирской медицины. 2018. № 4. C. 264–280. [Ostanko VL, Kalacheva TP, Kalyuzhina EV, et al. Biological markers in the stratification of the risk of development and progression of cardiovascular pathology: present and future. Bulletin Siberian Med. 2018;(4):264–280. (In Russ).] doi: 10.20538/1682-0363-2018-4-264-280</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Vukicevic P, Klisic A, Neskovic V, et al. Oxidative stress in patients before and after on-pump and off-pump coronary artery bypass grafting: relationship with syntax score. Oxid Med Cell Longev. 2021;2021:3315951. doi: 10.1155/2021/3315951</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Wysocka A, Cybulski M, Berbeć H, et al. Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery. BMC Cardiovasc Disord. 2017;17(1):92. doi: 10.1186/s12872-017-0528-z</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Gorki H, Hoenicka M, Rupp P, et al. Similarity of coagulation and inflammation despite different surgical revascularization strategies — a prospective randomized trial. Perfusion. 2016; 31(8):640–647. doi: 10.1177/0267659116649426</mixed-citation></ref></ref-list></back></article>
